| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 0.40% |
| NAV | ₹122.62 (19 Oct 2020) |
|---|---|
| Fund Started | 10 Aug 2020 |
| Fund Size | ₹25 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Divi's Laboratories Ltd. | Healthcare | Equity | 5.2% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 5.2% |
| Dabur India Ltd. | FMCG | Equity | 4.3% |
| HCL Technologies Ltd. | Technology | Equity | 4.2% |
| Asian Paints Ltd. | Chemicals | Equity | 4.1% |
| Wipro Ltd. | Technology | Equity | 4.0% |
| Nestle India Ltd. | FMCG | Equity | 3.9% |
| Colgate-Palmolive (India) Ltd. | FMCG | Equity | 3.8% |
| Marico Ltd. | FMCG | Equity | 3.7% |
| Berger Paints India Ltd. | Chemicals | Equity | 3.7% |
ICICI Prudential Alpha Low Vol 30 ETF Growth is a Equity Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was made available to investors on 10 Aug 2020. Kayzad Eghlim is the Current Fund Manager of ICICI Prudential Alpha Low Vol 30 ETF Growth fund.The fund currently has an Asset Under Management(AUM) of ₹25 Cr and the Latest NAV as of 19 Oct 2020 is ₹122.62.
The ICICI Prudential Alpha Low Vol 30 ETF Growth is rated Moderately High risk.